NovaHep is a biotechnology company – a pioneer within the field of regenerative medicine, developing stem cell technology for generating human tissues that can be used in reconstructive surgery or for toxicity and biocompatibility studies. The main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. With a unique, patented and improved alternative to traditional treatments, NovaHep strives to deliver a life changing impact to patients and provide for major benefits for hospitals, healthcare providers and society – globally.
Leveraging on great achievements, the future is bright – full of hope and life for patients with life-threatening diseases. The research and development activities of NovaHep – leading to innovative and ground-breaking technology, methods and products – represent an enormous potential. We dream of the day of tomorrow… of one day being able to engineer entire organs – tailor-made livers, hearts and other complicated organs for transplantation. NovaHep – providing “Vessels for LIFE”.